Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Change in Inventory (2016 - 2017)

Lisata Therapeutics' Change in Inventory history spans 8 years, with the latest figure at -$43657.0 for Q1 2017.

  • For Q1 2017, Change in Inventory fell 104.06% year-over-year to -$43657.0; the TTM value through Mar 2017 reached -$447537.0, down 222.67%, while the annual FY2016 figure was $670555.0, 94.5% up from the prior year.
  • Change in Inventory reached -$43657.0 in Q1 2017 per LSTA's latest filing, up from -$733679.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.2 million in Q2 2016 to a low of -$1.5 million in Q2 2013.
  • Average Change in Inventory over 5 years is $142683.2, with a median of $375131.0 recorded in 2015.
  • Peak YoY movement for Change in Inventory: tumbled 594.6% in 2013, then soared 412.85% in 2015.
  • A 5-year view of Change in Inventory shows it stood at $740857.0 in 2013, then tumbled by 42.68% to $424687.0 in 2014, then crashed by 202.87% to -$436876.0 in 2015, then plummeted by 67.94% to -$733679.0 in 2016, then skyrocketed by 94.05% to -$43657.0 in 2017.
  • Per Business Quant, the three most recent readings for LSTA's Change in Inventory are -$43657.0 (Q1 2017), -$733679.0 (Q4 2016), and -$833800.0 (Q3 2016).